Filing Details

Accession Number:
0001209191-14-062661
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-09 16:49:15
Reporting Period:
2014-10-07
Filing Date:
2014-10-09
Accepted Time:
2014-10-09 16:49:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496671 Calithera Biosciences Inc. CALA Pharmaceutical Preparations (2834) 272366329
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1270734 Deepika Pakianathan C/O Delphi Ventures,
3000 Sand Hill Road, Bldg. 1, Suite 135
Menlo Park CA 94025
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-07 1,908,073 $0.00 1,908,073 No 4 C Indirect Delphi Ventures VIII, L.P.
Common Stock Acquisiton 2014-10-07 18,629 $0.00 18,629 No 4 C Indirect Delphi BioInvestments VIII, L.P.
Common Stock Acquisiton 2014-10-07 495,165 $10.00 2,403,238 No 4 P Indirect Delphi Ventures VIII, L.P.
Common Stock Acquisiton 2014-10-07 4,835 $10.00 23,464 No 4 P Indirect Delphi BioInvestments VIII, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect Delphi Ventures VIII, L.P.
No 4 C Indirect Delphi BioInvestments VIII, L.P.
No 4 P Indirect Delphi Ventures VIII, L.P.
No 4 P Indirect Delphi BioInvestments VIII, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Acquisiton 2014-10-07 6,808 $0.00 6,808 $0.00
Common Stock Series A Preferred Stock Acquisiton 2014-10-07 66 $0.00 66 $0.00
Common Stock Series B Preferred Stock Acquisiton 2014-10-07 415,128 $0.00 415,128 $0.00
Common Stock Series B Preferred Stock Acquisiton 2014-10-07 4,053 $0.00 4,053 $0.00
Common Stock Series C Preferred Stock Acquisiton 2014-10-07 740,312 $0.00 740,312 $0.00
Common Stock Series C Preferred Stock Acquisiton 2014-10-07 7,228 $0.00 7,228 $0.00
Common Stock Series D Preferred Stock Acquisiton 2014-10-07 745,825 $0.00 745,825 $0.00
Common Stock Series D Preferred Stock Acquisiton 2014-10-07 7,282 $0.00 7,282 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The preferred stock automatically converted into Common Stock on a one-for-one basis immediately upon the consummation of Issuer's initial public offering of Common Stock and had no expiration date.
  2. The securities are directly held as follows: 2,403,238 shares by Delphi Ventures VIII, L.P. ("DV VIII") and 23,464 shares held by Delphi BioInvestments VIII, L.P. ("DBI VIII" and together with DV VIII, the "Delphi VIII Funds"). Delphi Management Partners VIII, L.L.C. ("DMP VIII") is the general partner of each of DV VIII and DBI VIII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VIII Funds. The Reporting Person is a managing member of DMP VIII and may be deemed to share voting and dispositive power over the securities held by the Delphi VIII Funds. The Reporting Person disclaims beneficial ownership of the securities held by Delphi VIII Funds, except to the extent of any pecuniary interest therein.